A detailed history of Vident Advisory, LLC transactions in Exscientia PLC stock. As of the latest transaction made, Vident Advisory, LLC holds 14,355 shares of EXAI stock, worth $69,478. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,355
Holding current value
$69,478
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.26 - $6.0 $61,152 - $86,130
14,355 New
14,355 $70.1 Million
Q1 2024

May 14, 2024

BUY
$5.3 - $7.51 $113,700 - $161,112
21,453 New
21,453 $123 Million

Others Institutions Holding EXAI

About Exscientia plc


  • Ticker EXAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,461,000
  • Market Cap $593M
  • Description
  • Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...
More about EXAI
Track This Portfolio

Track Vident Advisory, LLC Portfolio

Follow Vident Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Advisory, LLC with notifications on news.